ANGELA AKERS: Open Payments
NPI 1497240774 · PRINCETON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 57 payments from 12 companies in 2025. Trend: 2023 $1,666 · 2024 $1,167 · 2025 $977
Food & beverage: $977
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $295 |
| ABBVIE INC. | 15 | $277 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $102 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $64 |
| Lilly USA, LLC | 3 | $56 |
| Abbott Laboratories | 2 | $42 |
| Exact Sciences Corporation | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: Ozempic, VRAYLAR, Kerendia, Rybelsus, XIFAXAN, MOUNJARO, QULIPTA, FREESTYLE LIBRE 2.
Industry payments across WV — which companies pay providers there.
